Mosaic ImmunoEngineering, Inc. Share Price
Equities
CPMV
US61945M1018
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3131 USD | +0.03% | -22.11% | -47.82% |
15/04 | Mosaic ImmunoEngineering, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
28/03 | Mosaic ImmunoEngineering, Inc. Receives Letter of Termination from CWRU | CI |
Sales 2022 | - | Sales 2023 | - | Capitalization | 4.35M 362M |
---|---|---|---|---|---|
Net income 2022 | -2M -167M | Net income 2023 | -1M -83.38M | EV / Sales 2022 | - |
Net Debt 2022 | 1.01M 84.02M | Net Debt 2023 | 1.16M 96.83M | EV / Sales 2023 | - |
P/E ratio 2022 |
-3
x | P/E ratio 2023 |
-4.29
x | Employees | 6 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 11.28% |
1 day | +0.03% | ||
1 week | -22.11% | ||
Current month | -3.15% | ||
1 month | -10.16% | ||
3 months | -43.07% | ||
6 months | -45.07% | ||
Current year | -47.82% |
Managers | Title | Age | Since |
---|---|---|---|
Steven W. King
FOU | Founder | 59 | 21/20/21 |
Paul Lytle
FOU | Founder | 55 | 24/92/24 |
Director/Board Member | 64 | 01/01/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Garnick
FOU | Founder | 74 | 21/20/21 |
Director/Board Member | 64 | 01/01/01 | |
Steven W. King
FOU | Founder | 59 | 21/20/21 |
Date | Price | Change | Volume |
---|---|---|---|
24/24/24 | 0.3131 | +0.03% | 510 |
22/24/22 | 0.313 | -22.13% | 1,675 |
19/24/19 | 0.402 | +22.25% | 1,014 |
Delayed Quote OTC Markets, April 24, 2024 at 11:48 pm IST
More quotes1st Jan change | Capi. | |
---|---|---|
-47.82% | 2.27M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- CPMV Stock